SenesTech (NASDAQ:SNES) Coverage Initiated by Analysts at StockNews.com

by · The Cerbat Gem

Equities research analysts at StockNews.com assumed coverage on shares of SenesTech (NASDAQ:SNES – Get Free Report) in a research report issued on Sunday. The brokerage set a “sell” rating on the stock.

Separately, HC Wainwright raised their target price on SenesTech from $3.50 to $10.00 and gave the stock a “buy” rating in a research report on Thursday, December 12th.

View Our Latest Report on SNES

SenesTech Trading Down 6.6 %

NASDAQ:SNES opened at $2.97 on Friday. The company has a debt-to-equity ratio of 0.05, a current ratio of 6.32 and a quick ratio of 4.92. The firm has a 50-day moving average price of $2.82 and a 200 day moving average price of $3.37. SenesTech has a 12-month low of $1.90 and a 12-month high of $13.30.

SenesTech Company Profile

(Get Free Report)

SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.

Featured Articles